Dr Reddy’s Laboratories has expanded its generic semaglutide portfolio with Obeda Pro and Obeda Plus after supplies of its original Obeda i...

Jubilant Pharmova plans to raise around Rs 14 billion ($150 million) through a three-year rupee bond offering to fund capital expenditure a...

Govt has told Supreme Court that hospitals overcharging patients for medicines and medical consumables is a malpractice. Its affidavit cite...

During the vibrant festive season, OnePlus is rolling out enticing discounts on an array of smartphones, tablets, and audio devices. The Di...

Arvind Kejriwal criticised Amit Shah for the ongoing drug issues in BJP-ruled states like Bihar and Gujarat. Shah had expressed his sadness...

Consumers in the US are experiencing significant changes in their wardrobes due to weight-loss medications. Many individuals are opting for...

Sanofi Healthcare has obtained authorisation from the Central Drugs Standard Control Organisation for Qfitlia. This therapy is designed to ...

Galderma, Natura, and L'Oreal are developing treatments for consumers experiencing facial sagging due to rapid weight loss. These companies...

Dr Reddy's Laboratories has received approval for Zytorvi, an immunotherapy targeting advanced esophageal squamous cell carcinoma. This new...

Hibsago, GSK's new hepatitis B treatment, recently secured approval from the US FDA, allowing patients to better manage their condition aft...

Union Home Minister Amit Shah recently visited Punjab, where he met families impacted by drug abuse. He specifically visited Gurdaspur, San...

The growing use of GLP-1 weight-loss drugs such as Ozempic and Wegovy is driving demand for dietary supplements in the US, as users seek to...

Mochi Health has reduced their prices for their GLP-1 weight loss medications. While the membership fees is entirely separate, they have me...

In ‘Connecting the Dots’ report, Goldman Sachs highlights how businesses are controlling AI bills by setting usage limits, removing tools t...

India's National Pharmaceutical Pricing Authority has capped trade margins for 137 anti-cancer drugs at 30% of their maximum retail price. ...

For millions of cancer patients, the cost of treatment can be as frightening as the diagnosis. From steep markups to patented drugs that re...

The Kerala High Court has stressed the importance of making cancer medicines like ribociclib more affordable for patients. The Government o...